Manchester, NH – In a move to once again place their stake a bit deeper into the healthcare landscape, Amazon recently announced the purchase of the successful online pharmacy, PillPack. As reported by Ed Silverman, Senior Writer at Stat News, the young company makes it simpler for people with co-morbidities to receive and manage their daily medication needs. The personal touches already in place with PillPack’s fit perfectly within Amazon’s already rich mission statement and what their customers have already come to love.
“PillPack’s visionary team has a combination of deep pharmacy experience and a focus on technology,” said Jeff Wilke, who heads the Amazon worldwide consumer business, in a statement. “PillPack is meaningfully improving its customers’ lives, and we want to help them continue making it easy for people to save time, simplify their lives, and feel healthier. We’re excited to see what we can do together on behalf of customers over time.”
According to RBC Capital Market’s analyst, George Hill, PillPack is dispensing about 1.25 million to 1.5 million prescriptions a year. Combine that with Amazon’s already powerful backend and those existing customers will have a plethora of new products and solutions available at their fingertips.
You can read all of Ed’s report here, originally reported on Stat News.
Why This Matters –
Amazon’s disruption in the healthcare landscape continues to get deeper and closer to bringing new and innovative solutions to the market. This move follows several trends we’re following this year. These shifts dive deep into bringing prescriptions to your doorstep in new ways like PillPack has started as well as blockchain being the new backbone for an era of information security; a crucial part of merging personal healthcare information and a powerhouse like Amazon.
And while it will take a while to realize the benefits, it will be interesting to watch what Amazon’s entry into the pharmacy business will do for adherence, PBMs in general and how their new partnership with JP Morgan and Berkshire will influence the price debate. All topics we will be eagerly watching and reporting as it happens.